𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Access to health care in a system transition: the case of Bulgaria

✍ Scribed by Dina Balabanova; Martin McKee


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
188 KB
Volume
17
Category
Article
ISSN
0749-6753

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Objective

Throughout the 1990s, the Soviet‐style model in central and eastern Europe that provided free health services has been subject to radical reforms. Socio‐economic inequalities have also increased but there is little information on inequalities in health care utilization. This paper examines the pattern of illness behaviour in Bulgaria, seeking evidence of inequalities in access to services and eliciting users' pathways to care.

Design

Analysis drew on a representative population survey in Bulgaria (1997). The financial determinants of service use were tested in a multivariate model adjusted first for age, and then for age, marital status and self‐reported health. In‐depth interviews with users and providers addressed pathways to care, use of connections and other informal strategies to obtain care.

Results

As expected, rates of illness vary with income, with highest rates among the poor. After adjustment for illness, consultation rates are relatively equal across income levels, with the exception of worse‐off women who tend to consult more. For first contact, there are few differences according to income, with the better off preferring secondary level. Pathways slightly differ, with women more often treated in primary care. Private sector utilization is low. Qualitative research reveals well‐established strategies to obtain more advanced care, including use of connections, informal payments and use of emergency services.

Conclusions

An apparent lack of inequalities in access to care conceals a more complex picture in which income and gender influence the pathways taken through the system. Copyright © 2000 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


The importance of quality, access and pr
✍ Milena Pavlova; Wim Groot; Godefridus van Merode 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

## Abstract One approach to the problem of low patient satisfaction in Bulgaria is to identify attributes of health care services that the consumers value most and to focus on their improvement. Based on data from a household survey, this paper examines the importance that health care consumers att

Access to health care resources in the U
✍ Carol Propper; Jenny Eachus; Philip Chan; Nicky Pearson; George Davey Smith 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

The paper uses new and detailed data from a population sample of individuals with arthritis to examine the impact of objective measures of need for treatment and individual measures of socio-economic position on the distribution of public and private health care. The quality of the data and the rang

Curing a meagre health care system by le
✍ Björn Trägårdh; Kajsa Lindberg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

## Abstract The purpose of this article is to discuss what happens when work embedded in a ‘meagre’†‘Meagre’ is chosen as a term to describe a critical state in an organizational field where resources are relatively scarce, i.e. in relation to the prescribed task. ‘Lean’ is a term to describe an or

The diffusion of a pediatric care innova
✍ Michael C. Barth; Cynthia Hansel Sherlock 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

## Abstract This article documents and analyzes the diffusion of an innovation in pediatric primary care, the Healthy Steps for Young Children Program, in a large health care system, Advocate Health Care in Chicago. We use Everett Rogers's model (1995) for the diffusion of innovations to provide th

Commercialisation, inequality and the li
✍ Maureen Mackintosh 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

The effects of commercialised health care in embedding, exacerbating and legitimating social and economic inequality are at the root of widespread and recurrent resistance to commercialisation in health. In low income developing countries suffering generalised poverty, and notably in Sub-Saharan Afr